Enhancing RNA vaccine safety through localized delivery strategies.
作者信息
Kimura Taishi
机构信息
HDT Bio, Seattle, WA, USA.
出版信息
Vaccine Insights. 2025 Mar;4(2):41-45. Epub 2025 Mar 20.
Abstract
摘要
相似文献
1
Enhancing RNA vaccine safety through localized delivery strategies.通过局部递送策略提高RNA疫苗安全性。
Vaccine Insights. 2025 Mar;4(2):41-45. Epub 2025 Mar 20.
2
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development.自扩增RNA：疫苗开发通用平台的优势与挑战
Viruses. 2025 Apr 14;17(4):566. doi: 10.3390/v17040566.
3
Beyond Needles: Immunomodulatory Hydrogel-Guided Vaccine Delivery Systems.超越针头：免疫调节水凝胶引导的疫苗递送系统
Gels. 2024 Dec 26;11(1):7. doi: 10.3390/gels11010007.
4
Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.合成RNA与传统疫苗联合给药可改善猪对口蹄疫病毒的免疫反应并提供保护。
Antiviral Res. 2017 Jun;142:30-36. doi: 10.1016/j.antiviral.2017.03.009. Epub 2017 Mar 16.
5
Strategies for enhancing immunity against avian influenza virus in chickens: a review.增强鸡对禽流感病毒免疫力的策略：综述。
Avian Pathol. 2022 Jun;51(3):211-235. doi: 10.1080/03079457.2022.2054309. Epub 2022 May 5.
6
Recent Advancement in mRNA Vaccine Development and Applications.mRNA疫苗开发与应用的最新进展
Pharmaceutics. 2023 Jul 18;15(7):1972. doi: 10.3390/pharmaceutics15071972.
7
Enhancing TB Vaccine Efficacy: Current Progress on Vaccines, Adjuvants and Immunization Strategies.提高结核病疫苗效力：疫苗、佐剂及免疫策略的当前进展
Vaccines (Basel). 2023 Dec 29;12(1):38. doi: 10.3390/vaccines12010038.
8
Progress Update on STING Agonists as Vaccine Adjuvants.作为疫苗佐剂的STING激动剂的进展更新
Vaccines (Basel). 2025 Mar 31;13(4):371. doi: 10.3390/vaccines13040371.
9
Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection.用工程益生菌罗伊氏乳杆菌进行口服疫苗接种对局部和全身性金黄色葡萄球菌感染具有保护作用。
Microbiol Spectr. 2023 Feb 1;11(2):e0367322. doi: 10.1128/spectrum.03673-22.
10
Microneedle-Enabled Breakthroughs in Nucleic Acid Therapeutics.核酸治疗领域基于微针技术的突破
Adv Healthc Mater. 2025 May 15:e2501015. doi: 10.1002/adhm.202501015.
本文引用的文献
1
mRNA vaccines for infectious diseases - advances, challenges and opportunities.传染病的 mRNA 疫苗：进展、挑战与机遇。
Nat Rev Drug Discov. 2024 Nov;23(11):838-861. doi: 10.1038/s41573-024-01042-y. Epub 2024 Oct 4.
2
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency.自我扩增RNA中经修饰核苷酸的完全取代可抑制干扰素反应并提高效力。
Nat Biotechnol. 2025 May;43(5):720-726. doi: 10.1038/s41587-024-02306-z. Epub 2024 Jul 8.
3
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.英格兰 510 万儿童接种 COVID-19 疫苗和感染后的安全结果。
Nat Commun. 2024 May 27;15(1):3822. doi: 10.1038/s41467-024-47745-z.
4
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.一种针对奥密克戎的、自我扩增的 COVID-19 mRNA 加强疫苗：一项 2/3 期随机试验。
Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18.
5
Overview of U.S. COVID-19 vaccine safety surveillance systems.美国 COVID-19 疫苗安全监测系统概述。
Vaccine. 2024 Sep 17;42 Suppl 3:125748. doi: 10.1016/j.vaccine.2024.02.065. Epub 2024 Apr 16.
6
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine.VLPCOV-02的安全性和免疫原性，一种带有修饰碱基5-甲基胞嘧啶的新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）自我扩增RNA疫苗。
iScience. 2024 Jan 22;27(2):108964. doi: 10.1016/j.isci.2024.108964. eCollection 2024 Feb 16.
7
Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects.组合设计可离子化脂质纳米粒用于肌肉选择性 mRNA 递送，最大限度减少脱靶效应。
Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2309472120. doi: 10.1073/pnas.2309472120. Epub 2023 Dec 7.
8
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation.一种定位纳米载体配方可使多价复制 RNA 引发多靶免疫反应，并将全身性炎症控制在有限范围内。
Mol Ther. 2023 Aug 2;31(8):2360-2375. doi: 10.1016/j.ymthe.2023.06.017. Epub 2023 Jul 3.
9
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis.SARS-CoV-2 mRNA 疫苗相关心肌炎中的细胞因子病伴异常细胞毒性淋巴细胞和促纤维化髓系反应。
Sci Immunol. 2023 May 12;8(83):eadh3455. doi: 10.1126/sciimmunol.adh3455. Epub 2023 May 5.
10
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.一项关于自我扩增型新冠病毒mRNA疫苗的I/II期随机、双盲、安慰剂对照试验。
NPJ Vaccines. 2022 Dec 13;7(1):161. doi: 10.1038/s41541-022-00590-x.
Zotero 插件